The first proposed hypothesis for the role of serum irisin levels in CAD is that lower irisin levels cause endothelial dysfunction and reduced coronary blood flow due to reduced nitric oxide (NO) bioavailability. The gene discussed is FNDC5; the disease is endothelial dysfunction.